Lin S, Chen Y, Ho H, Huang W, Sheu M, Liu D
Int J Nanomedicine. 2013; 8:3455-66.
PMID: 24049445
PMC: 3775676.
DOI: 10.2147/IJN.S48465.
Singh A, Narsipur S
J Transplant. 2011; 2011:480642.
PMID: 22174986
PMC: 3235899.
DOI: 10.1155/2011/480642.
Lin Y, Wu J, Chen Y, Su Y, Ke W, Ho H
Int J Nanomedicine. 2011; 6:2445-57.
PMID: 22072880
PMC: 3205139.
DOI: 10.2147/IJN.S25339.
Saint-Marcoux F, Marquet P, Jacqz-Aigrain E, Bernard N, Thiry P, Le Meur Y
Clin Pharmacokinet. 2006; 45(9):905-22.
PMID: 16928152
DOI: 10.2165/00003088-200645090-00003.
Johnston A, Belitsky P, Frei U, Horvath J, Hoyer P, Helderman J
Eur J Clin Pharmacol. 2004; 60(6):389-95.
PMID: 15205865
DOI: 10.1007/s00228-004-0774-8.
Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic-genotypic correlates.
Balram C, Sharma A, Sivathasan C, Lee E
Br J Clin Pharmacol. 2003; 56(1):78-83.
PMID: 12848778
PMC: 1884331.
DOI: 10.1046/j.1365-2125.2003.01820.x.
Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC(0-12) monitoring in cardiac transplant recipients over the first year post-transplantation.
Monchaud C, Rousseau A, Leger F, David O, DeBord J, Dantoine T
Eur J Clin Pharmacol. 2003; 58(12):813-20.
PMID: 12698308
DOI: 10.1007/s00228-003-0559-5.
Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.
Dunn C, Wagstaff A, Perry C, Plosker G, Goa K
Drugs. 2001; 61(13):1957-2016.
PMID: 11708766
DOI: 10.2165/00003495-200161130-00006.
Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients.
Belitsky P, Dunn S, Johnston A, Levy G
Clin Pharmacokinet. 2000; 39(2):117-25.
PMID: 10976658
DOI: 10.2165/00003088-200039020-00003.